ROYAL BANK OF CANADA - WEREWOLF THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,000335
+16650.0%
0.00%
Q1 2023$020.0%0.00%
Q4 2022$0
-100.0%
2
-99.5%
0.00%
Q3 2022$2,000
+100.0%
387
+66.1%
0.00%
Q2 2022$1,000
-85.7%
233
-85.6%
0.00%
Q1 2022$7,000
-89.7%
1,622
-71.4%
0.00%
Q4 2021$68,000
+385.7%
5,680
+613.6%
0.00%
Q3 2021$14,000
+55.6%
796
+53.4%
0.00%
Q2 2021$9,0005190.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DC Funds, LP 589,102$2,409,00033.24%
MPM ASSET MANAGEMENT LLC 4,284,172$17,522,0007.39%
MPM BioImpact LLC 2,388,011$9,767,0002.71%
RA Capital Management 4,291,881$17,554,0000.47%
PFM Health Sciences, LP 1,730,723$7,079,0000.27%
SPHERA FUNDS MANAGEMENT LTD. 597,003$2,442,0000.26%
Oasis Management Co Ltd. 246,305$1,007,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 958,125$3,919,0000.08%
Rubric Capital Management LP 204,996$838,0000.04%
Laurion Capital Management LP 535,160$2,189,0000.03%
View complete list of WEREWOLF THERAPEUTICS INC shareholders